drugset / Trial / NCT01455194

Effect of High Dose Ciclesonide on Asthma Control

NCT01455194

Phase 3 Completed 520 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the trial is to investigate asthma control with 160 to 640 mcg ciclesonide/day. Asthma control will be assessed by the Asthma Control Questionnaire (ACQ).

Timeline

Start
2011-11
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ciclesonide Other / unclassified 80 ug Inhaled
Comparator Ciclesonide Other / unclassified 160 ug Inhaled
Comparator Ciclesonide Other / unclassified 320 ug Inhaled

Indications